Molecular Imaging Services

Molecular imaging can be applied at all stages of drug discovery and development - from validating disease-relevant targets to pre-clinical evaluation and selection of drug candidates - through to clinical development and post-marketing surveillance.

A global leader and proven partner in isotopes and radiopharmaceutical services, MDS Nordion is establishing a reliable quality offering in molecular imaging services to leading biotechnology and pharmaceutical companies. Studies are tailored to customers' needs and can range from studies using existing tracers and normal animals to complex tracers and transgenic animals.

Our capabilities include:

• Skilled multidisciplinary and dedicated molecular imaging team including biologists, chemists, and imaging physicists
• Pre-clinical single photon emission computed tomography (SPECT/CT) and positron emission tomography/computed tomography (PET/CT) capabilities, and clinical PET/CT capabilities
• Dedicated labs in a confidential environment
• Studies ranging from, but not limited to:
  • Target identification/targeting
  • Receptor binding/occupancy
  • Pharmacokinetics(PK) / Pharmacodynamics (PD)
  • Dose ranging
  • Drug delivery
  • Validation
  • Translational imaging possibilities